Association of nonalcoholic fatty liver disease and liver cancer

doi:10.3748/wjg.v21.i3.913

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6823)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

521

WORD

181

HTML

3569

Tables (1-3)

123

Sum=4394

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1009

Download

1420

Sum=2429

Jan 21, 2015 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jan 21, 2015; 21(3): 913-918
Published online Jan 21, 2015. doi: 10.3748/wjg.v21.i3.913

Table 1 Neoplasms of 120 patients with primary and secondary hepatic neoplasm n (%)

Neoplasms	Incidence rate	Age, yr	Sex (male)	Steatosis	Fibrosis	NASH
NCLM	48 (40.0)	56.9	19 (39.6)	11 (22.9)	24 (50.0)	2 (4.2)
LMCC	40 (33.3)	57.5	25 (62.5)	22 (55.0)	15 (37.5)	0 (0.0)
HCC	16 (13.3)	57.9	13 (81.3)	4 (25.0)	12 (75.0)	0 (0.0)
IHCC	11 (9.2 )	63.3	2 (18.2)	3 (27.3)	7 (63.6)	0 (0.0)
Others	5 (4.2)	64.4	0 (0.0)	1 (20.0)	2 (40.0)	0 (0.0)

HCC: Hepatocellular carcinoma; IHCC: Intrahepatic cholangiocarcinoma; LMCC: Liver metastasis of colorectal cancer; NASH: Nonalcoholic steatohepatitis; NCLM: Non-colorectal liver metastasis; Others: Lymphoproliferative tumors and sarcoma.

Table 2 Association of risk factors for nonalcoholic fatty liver disease with steatosis and liver fibrosis in 120 patients with primary and secondary hepatic neoplasm

NAFLD riskfactor (n)	Liver steatosis			Liver fibrosis
NAFLD riskfactor (n)	n (%)	P value	OR (95%CI)	n (%)	P value	OR (95%CI)
GI and/or DM (41)	14 (34.1)	0.182	1.70 (0.78 -3.71)	31 (51.7)	0.196	0.62 (0.30-1.28)
Dyslipidemia (17)	9 (52.9)	0.078	2.50 (0.88-7.06)	8 (47.1)	0.793	0.87 (0.31-2.44)
Hypertension (55)	24 (43.6)	< 0.001¹	3.99 (1.73-9.16)	31 (56.4)	0.200	1.60 (0.78-3.31)
Overweight (53)	26 (49.1)	0.002	3.76 (1.56-9.05)	30 (56.6)	0.165	1.74 (0.79-3.81)

¹A statistically significant difference. DM: Diabetes mellitus; GI: Glucose intolerance; NAFLD: Nonalcoholic fatty liver disease.

Table 3 Prevalence of steatosis and hepatic fibrosis according to type of hepatic neoplasm

Histologic type (n)	Liver steatosis			Liver fibrosis
Histologic type (n)	n (%)	P value	OR (95%CI)	n (%)	P value	OR (95%CI)
LMCC (40)	22 (55.0)	< 0.001¹	3.99 (1.78-8.94)	15 (37.5)	0.053	0.47 (0.21-1.02)
NCLM (48)	11 (22.9)	0.034	0.42 (0.18-0.95)	24 (50.0)	1.000	1.00 (0.48-2.08)
HCC (16)	4 (25.0)	0.406	0.60 (0.18-2.01)	12 (75.0)	0.032¹	3.50 (1.06-11.57)
IHCC (11)	3 (27.3)	0.613	0.70 (0.18-2.80)	7 (63.6)	0.343	1.85 (0.51-6.68)

¹A statistically significant difference. HCC: Hepatocellular carcinoma; IHCC: Intrahepatic cholangiocarcinoma; LMCC: Liver metastasis of colorectal cancer; NCLM: Non-colorectal liver metastasis.

Citation: Schulz PO, Ferreira FG, Nascimento MFA, Vieira A, Ribeiro MA, David AI, Szutan LA. Association of nonalcoholic fatty liver disease and liver cancer. World J Gastroenterol 2015; 21(3): 913-918
URL: https://www.wjgnet.com/1007-9327/full/v21/i3/913.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i3.913